Researchers Develop a Precision Medicine Model to Personalize Depression Treatment

Depression affects people in different ways, with biological, psychological, and social factors all influencing how symptoms develop and respond to treatment. This complexity makes it difficult for clinicians to predict which therapy will be most effective for an individual patient when treatment begins.

Researchers from the University of Alberta and Radboud University in the Netherlands are leading an international project designed to address this challenge. Their long-term goal is to develop a precision mental health tool capable of recommending personalized depression treatments based on each patient's individual clinical profile.

Moving Beyond Trial-and-Error Treatment

Treatment for depression often begins with a process of trial and error, in which patients may try multiple medications or psychotherapies before finding an effective approach. According to senior author Zachary Cohen, approximately half of patients do not respond to the first treatment they receive, prolonging symptoms and increasing healthcare costs.

The researchers argue that depression care should increasingly resemble the precision medicine approaches used in fields such as oncology and cardiology. Rather than relying solely on generalized treatment guidelines, clinicians could receive personalized recommendations based on factors including a patient's age, sex, symptom profile, and co-occurring mental health conditions.

One of the Largest Depression Treatment Databases

To support this goal, the research team assembled data from more than 60 randomized clinical trials conducted around the world involving adults diagnosed with depression. Altogether, the combined dataset includes nearly 10,000 patients, making it one of the largest collections of depression treatment data assembled for this type of research.

The clinical trials evaluated five commonly used treatment approaches: antidepressant medication, cognitive therapy, behavioral therapy, interpersonal therapy, and short-term psychodynamic therapy. Before treatment began, participants also underwent assessments covering a range of clinical characteristics, including anxiety symptoms and personality disorders.

Developing a Personalized Clinical Decision Tool

Lead researcher Ellen Driessen explained that the team is investigating whether patients with particular characteristics—such as co-occurring anxiety disorders or specific personality traits—respond more favorably to certain treatments than others. The ultimate objective is to translate these findings into a practical clinical decision support tool.

The researchers envision a straightforward software program or web-based application into which clinicians would enter a patient's demographic and clinical information. The system would then generate a personalized treatment recommendation rather than presenting a broad list of possible options, as current clinical guidelines often do.

A Decade-Long International Collaboration

The project has required extensive collaboration among researchers from multiple countries who agreed to share the original data from their clinical trials. According to Cohen, collecting, standardizing, and preparing the combined dataset for analysis has already required approximately five years of work.

The team's study, published in PLOS One, describes the project's methodology and planned analytical approach. During the next one to two years, the researchers aim to develop and validate predictive models capable of identifying the treatments most likely to benefit individual patients across diverse populations.

Potential Impact on Depression Care

Once the predictive model has been completed, the researchers plan to evaluate it in a new clinical trial. The study will compare outcomes between patients whose treatment is guided by the decision support tool and those receiving standard clinical care without algorithm-assisted recommendations.

If the approach improves treatment response rates, the researchers believe it could eventually be implemented in routine clinical practice, helping healthcare professionals make more efficient use of psychotherapy and medication while reducing the time patients spend searching for an effective treatment.

Cohen also notes that the proposed system could be broadly applicable because it relies primarily on information that is already routinely collected in mental health care, including demographic characteristics and self-report questionnaires. This could make personalized treatment recommendations accessible in a wide range of healthcare settings around the world.